Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00232830 | The Study to Assess AMI Treated With Balloon Angioplasty. | PHASE3 | COMPLETED | 715 | — | — | Oct 1, 2003 | Apr 1, 2009 | Sep 16, 2009 | 2 | France, Germany |
| NCT00235170 | The Arterial Revascularization Therapies Study Part II. | PHASE3 | COMPLETED | 607 | — | — | Feb 1, 2003 | Apr 1, 2009 | May 5, 2009 | 1 | Netherlands |
| NCT00381420 | The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. | PHASE3 | COMPLETED | 100 | — | — | Mar 1, 2001 | Jun 1, 2008 | Oct 31, 2008 | - | — |
| NCT00234455 | A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. | PHASE2 | COMPLETED | 86 | — | — | Jun 1, 2001 | Apr 1, 2007 | Apr 30, 2008 | 1 | Italy |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Cypher Sirolimus-eluting Coronary Stent |
| 2 | ACTIVE_COMPARATOR | Bare-metal stent |
| Name | Type | Description |
|---|---|---|
| drug-eluting stent | DEVICE | Cypher Sirolimus-eluting Coronary Stent |
| bare-metal stent | DEVICE | any bare-metal stent brand |
| drug eluting-stent | DEVICE | PCI |
Inclusion Criteria: 1. Have prolonged, continuous (lasting at least 20 minutes) chest pain despite administration of nitrates and onset within 12 hours of randomization, and one of the following: 1. ST segment elevation \>=1mm in standard leads and \>=2mm in 2 or more contiguous precordial lead...